1  coli to confer survival upon challenge with carbenicillin.

2 mally non-transported beta-lactam antibiotic carbenicillin.

3 avoid toxic compounds such as the antibiotic carbenicillin.

4 was shown to be unaffected by treatment with carbenicillin, an inhibitor of bacterial cell wall biosy

5 ed to two important beta-lactam antibiotics, carbenicillin and ceftazidime.

6 lts in a moderate increase in the ofloxacin, carbenicillin, and tobramycin MICs.

7                                              Carbenicillin appeared to be completely ineffective agai

8 roteins into VLPs in Escherichia coli when a carbenicillin, but not a kanamycin, selection marker was

9 eated cells with sublethal concentrations of carbenicillin (Cb) to assess the role of penicillin-bind

10 onjugation-mediated plasmid transfer and (5) carbenicillin, gentamicin (Gm) and tetracycline selectab

11 streptomycin, sulfanilamide, gentamicin, and carbenicillin in 1975.

12 in expression were seen during IFN-gamma and carbenicillin-induced persistence and reactivation.

13 (ii) IFN-gamma-induced persistence and (iii) carbenicillin-induced persistence.

14 metabolically active, whilst AMR bacteria to carbenicillin, kanamycin and both two antibiotics were 3

15                            Binding of either carbenicillin or ceftazidime to purified PBP3 increases

16 n alone were different from those found with carbenicillin or ciprofloxacin alone, but there were man

17 etween the combination (13-fosmidomycin) and carbenicillin or ciprofloxacin, reflecting the more pote

18 ompound from this study potently suppressing carbenicillin resistance in multiple M. tuberculosis str

19 ence of other antibiotics (ciprofloxacin and carbenicillin) that have similar effects on bacterial gr

20 decrease in efficiency was not observed when carbenicillin was omitted from the final expression cult

21 EM-1 (with benzylpenicillin) and PSE-4 (with carbenicillin) were recorded (totaling 4.0 mus).